Exploring the binding mechanism of HDAC8 selective inhibitors: Lessons from the modification of Cap group
{{output}}
The abnormal expression of histone deacetylase 8 (HDAC8) has been reported to associate with various cancer entities (colon, breast cancer, pancreas, etc.) as well as parasitic diseases, making HDAC8 gradually develop into an attractive and potential therapeut... ...
